Equillium (EQ) Enterprise Value (2018 - 2026)
Equillium (EQ) posted quarterly Enterprise Value of -$61.3 million for Q1 2026, down 322.91% year-over-year from $27.5 million in Q1 2025, and down 106.24% quarter-over-quarter from -$29.7 million in Q4 2025.
Analysis
Equillium (EQ) Enterprise Value (2018 - 2026) Analysis & Trends
Equillium (EQ) has reported Enterprise Value for 10 consecutive years, with -$61.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 322.91% year-over-year to -$61.3 million; the TTM figure through Mar 2026 stood at -$61.3 million (down 322.91% YoY), while the FY2025 annual figure was -$29.7 million, down 31.71% from the prior year.
- Enterprise Value retreated to -$61.3 million in Q1 2026 per EQ's latest filing, from -$29.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$10.3 million in Q2 2025 and bottomed at -$71.0 million in Q4 2022.
- Historically, Enterprise Value has averaged -$41.3 million across 5 years, with a median of -$40.9 million in 2023.
- Annual changes were most pronounced in 2025 — Enterprise Value surged 69.17% — and 2026, when it tumbled 322.91%.
- Equillium's Enterprise Value stood at -$71.0 million in 2022, then soared by 42.46% to -$40.9 million in 2023, then surged by 44.76% to -$22.6 million in 2024, then plunged by 31.71% to -$29.7 million in 2025, then sank by 106.24% to -$61.3 million in 2026.
- Business Quant data shows EQ's Enterprise Value at -$61.3 million in Q1 2026, -$29.7 million in Q4 2025, and -$33.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Equillium | 249.33 Mn | 249.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 300.58 Mn |
| Mar 31, 2026 | 131.24 Mn |
| Dec 31, 2025 | 64.99 Mn |
| Sep 30, 2025 | 53.65 Mn |
| Jun 30, 2025 | -241,271.25 |
| Mar 31, 2025 | -489,311.59 |
| Dec 31, 2024 | 3.17 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | -8.74 Mn |
| Mar 31, 2024 | 49.15 Mn |
| Dec 31, 2023 | -15.38 Mn |
| Sep 30, 2023 | -20.32 Mn |
| Jun 30, 2023 | -22.45 Mn |
| Mar 31, 2023 | -36.87 Mn |
| Dec 31, 2022 | -34.54 Mn |
| Sep 30, 2022 | 31.74 Mn |
| Jun 30, 2022 | 12.52 Mn |
| Mar 31, 2022 | 39.15 Mn |
| Dec 31, 2021 | 30.34 Mn |
| Sep 30, 2021 | 109.70 Mn |